
Keywords: AF; atrial fibrillation; CVA; cerebrovascular accident; MPO; myeloperoxidase; NO; nitric oxide; LVEF; left ventricular ejection fraction; ADMA; asymmetric dimethylarginine; SDMA; symmetric dimethylarginine; TSP-1; thrombospondin-1; Txnip; thioredoxin-inte